Free Trial

InflaRx (IFRX) Competitors

InflaRx logo
$0.91 +0.02 (+1.73%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$0.94 +0.03 (+2.79%)
As of 08/22/2025 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IFRX vs. CRGX, HRTX, OGI, PRQR, AVTE, SOPH, LYEL, MNPR, GNFT, and IPHA

Should you be buying InflaRx stock or one of its competitors? The main competitors of InflaRx include CARGO Therapeutics (CRGX), Heron Therapeutics (HRTX), Organigram Global (OGI), ProQR Therapeutics (PRQR), Aerovate Therapeutics (AVTE), SOPHiA GENETICS (SOPH), Lyell Immunopharma (LYEL), Monopar Therapeutics (MNPR), GENFIT (GNFT), and Innate Pharma (IPHA). These companies are all part of the "pharmaceutical products" industry.

InflaRx vs. Its Competitors

InflaRx (NASDAQ:IFRX) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment.

InflaRx currently has a consensus price target of $6.60, indicating a potential upside of 622.50%. CARGO Therapeutics has a consensus price target of $15.40, indicating a potential upside of 244.52%. Given InflaRx's stronger consensus rating and higher possible upside, analysts clearly believe InflaRx is more favorable than CARGO Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InflaRx
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
CARGO Therapeutics
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86

InflaRx has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500.

CARGO Therapeutics' return on equity of -43.21% beat InflaRx's return on equity.

Company Net Margins Return on Equity Return on Assets
InflaRxN/A -71.76% -57.68%
CARGO Therapeutics N/A -43.21%-37.26%

InflaRx has higher revenue and earnings than CARGO Therapeutics. InflaRx is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InflaRx$180K340.68-$49.85M-$0.80-1.14
CARGO TherapeuticsN/AN/A-$167.50M-$4.64-0.96

In the previous week, CARGO Therapeutics had 1 more articles in the media than InflaRx. MarketBeat recorded 3 mentions for CARGO Therapeutics and 2 mentions for InflaRx. CARGO Therapeutics' average media sentiment score of 0.38 beat InflaRx's score of 0.00 indicating that CARGO Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
InflaRx
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CARGO Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

42.4% of InflaRx shares are owned by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are owned by institutional investors. 16.3% of InflaRx shares are owned by company insiders. Comparatively, 2.9% of CARGO Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

InflaRx beats CARGO Therapeutics on 8 of the 14 factors compared between the two stocks.

Get InflaRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for IFRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IFRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IFRX vs. The Competition

MetricInflaRxMED IndustryMedical SectorNASDAQ Exchange
Market Cap$60.29M$3.11B$5.76B$9.58B
Dividend YieldN/A2.23%4.41%4.10%
P/E Ratio-1.1420.8831.1026.04
Price / Sales340.68349.56435.26103.29
Price / CashN/A43.1937.7358.48
Price / Book0.958.129.536.61
Net Income-$49.85M-$54.72M$3.26B$265.56M
7 Day Performance5.86%2.63%2.10%1.95%
1 Month Performance6.37%2.78%2.82%-0.37%
1 Year Performance-42.18%11.01%30.56%19.02%

InflaRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IFRX
InflaRx
2.5698 of 5 stars
$0.91
+1.7%
$6.60
+622.5%
-39.5%$60.29M$180K-1.1460News Coverage
High Trading Volume
CRGX
CARGO Therapeutics
2.0832 of 5 stars
$4.46
flat
$15.40
+245.3%
N/A$215.71MN/A-0.96116News Coverage
Analyst Upgrade
HRTX
Heron Therapeutics
4.2078 of 5 stars
$1.35
-3.6%
$4.50
+233.3%
-25.1%$214.61M$144.29M-67.50300Positive News
OGI
Organigram Global
0.3952 of 5 stars
$1.56
-2.5%
N/A-17.5%$214.44M$117.47M31.21860High Trading Volume
PRQR
ProQR Therapeutics
2.6847 of 5 stars
$2.02
flat
$8.00
+296.0%
+6.6%$212.53M$20.46M-4.39180
AVTE
Aerovate Therapeutics
N/A$7.33
-0.8%
N/A-88.5%$212.46MN/A-2.4520Gap Up
High Trading Volume
SOPH
SOPHiA GENETICS
2.9641 of 5 stars
$3.28
+5.5%
$8.00
+143.9%
+2.0%$210.17M$65.17M-7.45520Positive News
LYEL
Lyell Immunopharma
3.7546 of 5 stars
$10.76
-0.6%
$15.00
+39.4%
-62.9%$208.06M$60K-0.44270Positive News
MNPR
Monopar Therapeutics
2.8921 of 5 stars
$35.86
+7.0%
$60.00
+67.3%
+1,061.6%$206.76MN/A-10.7710
GNFT
GENFIT
2.186 of 5 stars
$4.11
+0.7%
$13.00
+216.3%
-2.8%$203.91M$76.77M0.00120News Coverage
Analyst Forecast
Analyst Revision
IPHA
Innate Pharma
1.721 of 5 stars
$2.18
-1.4%
$11.00
+404.6%
-0.4%$203.73M$21.77M0.00220Short Interest ↑
Gap Up

Related Companies and Tools


This page (NASDAQ:IFRX) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners